Show simple item record

dc.contributor.authorPalmer, D
dc.contributor.authorMoller, AS
dc.contributor.authorGreenhalf, B
dc.contributor.authorMa, YT
dc.contributor.authorValle, Juan W
dc.contributor.authorGjertsen, TJ
dc.contributor.authorKuryk, L
dc.date.accessioned2020-02-27T16:55:31Z
dc.date.available2020-02-27T16:55:31Z
dc.date.issued2019en
dc.identifier.citationPalmer D, Møller AS, Greenhalf B, Ma YT, Valle JW, Gjertsen TJ, et al. Multiple KRAS mutations detected by cancer related DNA in patients with resected pancreas adenocarcinoma during treatment with TG01/GM-CSF and gemcitabine (CT TG01-01). Annals of Oncology. 2019;30:xi7-xi8.en
dc.identifier.doi10.1093/annonc/mdz447.022en
dc.identifier.urihttp://hdl.handle.net/10541/622803
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz447.022en
dc.titleMultiple KRAS mutations detected by cancer related DNA in patients with resected pancreas adenocarcinoma during treatment with TG01/GM-CSF and gemcitabine (CT TG01-01)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMolecular and Clinical Cancer Medicine, University of Liverpool Cancer Research UK Center, Liverpool,en
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record